• Title/Summary/Keyword: Cancer diagnostics

Search Result 94, Processing Time 0.029 seconds

Clinical Diagnosis of Oral Cancer (구강암의 임상적 진단)

  • Choi, Sung Weon
    • The Journal of the Korean dental association
    • /
    • v.49 no.3
    • /
    • pp.136-145
    • /
    • 2011
  • Oral cavity cancer accounts for approximately 3-4% of all malignancies and is a significant worldwide health problem. The Korea Central Cancer Registry estimates that there will be approximately 1500 new cases of oral cancer in Korea. Oral cancer occurs most commonly in middle-aged and elderly individuals. The majority of oral malignancies occur as squamous cell carcinomas and despite remarkable advances in treatment modalities, the 5-year survival rate has not significantly improved over the past several decades, hovering at about 50% to 60%. The unfavorable 5-year survival rate may be attributable to several factors. First, oral cancer is often diagnosed at a late stage, with late stage 5-year survival rates as low as 22%. Additionally, the development of secondary primary tumors in patients with early stage disease has a major impact on survival. The early detection of oral cancer and premalignant lesions offers the promise to cure chance of oral cancer. The major diagnostics moddalities for oral cancer include oral cavity examination, supravital staining, oral cytology, and optical detection systems. But the clinical finding of oral mucosa is the most important key to confirm the oral cancer until now. The traditional clinical examination of oral cavity can be performed quickly, is without additional diagnostic expense to patients, and may be performed by health care professionals. Therefore, clinicians must be well-acquainted with clinical characteristics of oral cancer and practice routine screening for oral cancer in dental clinic to decrease the morbidity and mortality of disease.

Evaluating the progenitor cells of ovarian cancer: analysis of current animal models

  • King, Shelby M.;Burdette, Joanna E.
    • BMB Reports
    • /
    • v.44 no.7
    • /
    • pp.435-445
    • /
    • 2011
  • Serous ovarian cancer is one of the most lethal gynecological malignancies. Progress on effective diagnostics and therapeutics for this disease are hampered by ambiguity as to the cellular origins of this histotype of ovarian cancer, as well as limited suitable animal models to analyze early stages of disease. In this report, we will review current animal models with respect to the two proposed progenitor cells for serous ovarian cancer, the ovarian surface epithelium and the fallopian tube epithelium.

An Overview of Matrix Metalloproteinase 9 Polymorphism and Gastric Cancer Risk

  • Verma, Sugreev;Kesh, Kousik;Gupta, Arnab;Swarnakar, Snehasikta
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.16 no.17
    • /
    • pp.7393-7400
    • /
    • 2015
  • Matrix metalloproteinase (MMP) 9, a key member of multifunctional family of zinc dependent endopeptidases has been found to be upregulated during inflammation and in some cancers. MMPs cleave extracellular matrix (ECM) proteins and play critical roles in cellular apoptosis, angiogenesis, tumor growth and metastasis. Several genetic polymorphisms have been identified that show allele specific effects on MMP9 regulation and are associated with gastric cancer, the fourth most common malignancy in the world. Besides Helicobacter pylori infection, genetic predisposition is another documented risk factor for gastric carcinoma. The single nucleotide polymorphism (SNP) at position -1562C/T of MMP9 results in the modulation for binding of transcription factors to the MMP9 gene promoter and thereby causes differences in protein expression and enzymatic activity. MMP9 transcriptional regulation during gastric cancer development remains poorly known although several studies have demonstrated associations between MMP9 -1562 C/T polymorphism with different diseases. Knowledge on mechanisms of MMP9 upregulation during gastric cancer may provide new paradigm in diagnostics and therapeutics.

The Role of Korean Medicine for Treatment and Management for Lung Cancer (폐암 환자의 치료 및 관리에서 한의학적 치료의 역할)

  • Jung, Hyun-Jung;Kim, Jong-Dae
    • Journal of Korean Traditional Oncology
    • /
    • v.20 no.1
    • /
    • pp.45-54
    • /
    • 2015
  • Objectives : Lung cancer is the leading cause of death in cancer patients. Many studies reflect the growing application of integrative korean and western medicine for lung cancer, but its efficacy remains largely unexplored. The purpose of this study is to show that the role of Korean medicine for treatment and manage for lung cancer patients. Methods : In the present study, we searched all the clinical studies of Korean Medical therapies for lung cancer by electronic and manual searching in two databases including MEDLINE, OASIS. Results : Our study showed that acupuncture has strong immunomodulatory effect. Further analysis revealed that acupuncture and herb medicine alleviate the conventional therapy-induced bone marrow supression in lung cancer patients, as well as desease nausea and vomiting. In this study, we showed that acupuncture and herb medicine can improve immediate tumor response, quality of life of lung cancer patients. Conclusions : Korean medicine including that acupuncture and herb medicine is found to be effective in lung cancer treatment and management.

Pros and cons of using aberrant glycosylation as companion biomarkers for therapeutics in cancer

  • Kang, Jeong-Gu;Ko, Jeong-Heon;Kim, Yong-Sam
    • BMB Reports
    • /
    • v.44 no.12
    • /
    • pp.765-771
    • /
    • 2011
  • Cancer treatment has been stratified by companion biomarker tests that serve to provide information on the genetic status of cancer patients and to identify patients who can be expected to respond to a given treatment. This stratification guarantees better efficiency and safety during treatment. Cancer patients, however, marginally benefit from the current companion biomarker-aided treatment regimens, presumably because companion biomarker tests are dependent solely on the mutation status of several genes status quo. In the true sense of the term, "personalized medicine", cancer patients are deemed to be identified individually by their molecular signatures, which are not necessarily confined to genetic mutations. Glycosylation is tremendously dynamic and shows alterations in cancer. Evidence is accumulating that aberrant glycosylation contributes to the development and progression of cancer, holding the promise for use of glycosylation status as a companion biomarker in cancer treatment. There are, however, several challenges derived from the lack of a reliable detection system for aberrant glycosylation, and a limited library of aberrant glycosylation. The challenges should be addressed if glycosylation status is to be used as a companion biomarker in cancer treatment and contribute to the fulfillment of personalized medicine.

Expression of CD133, CD44, CK7, and OCT4 in Animal Cancers

  • Park, Jong-Ho;Cho, Eun-Sang;Ryu, Si-Yun;Jung, Ju-Young;Son, Hwa-Young
    • Korean Journal of Veterinary Research
    • /
    • v.53 no.2
    • /
    • pp.109-115
    • /
    • 2013
  • Cancers are mainly sustained by a small pool of neoplastic cells, known as cancer stem cells or tumorinitiating cells. These cells possess the ability to self-renew and proliferate, and are thus able to form the tumor. In the present study cells that correspond to cancer stem cells in mammary and liver cancers in animals were identified by the expression of CD133, CD44, CK7, and OCT4 using immunochemistry. As a result, we found with CD133+ and CD44+ cancer stem cell-like phenotypes in mouse and canine hepatocellular carcinoma and canine mammary gland tumors. However, CK7+ and OCT4+ cells were not identified in animal mammary and liver cancer. CD133+ and CD44+ cells are wellknown stem cell lines and play key roles in development and metastasis in human cancer. These findings suggest that cancer stem cells are involved in animal tumorigenesis and may provide insight into mechanisms in cancer development as well as cancer diagnostics.

Respiratory Review of 2012: Bronchoscopic Innovations and Advances

  • Nam, Sung-Jin;Hwangbo, Bin
    • Tuberculosis and Respiratory Diseases
    • /
    • v.73 no.4
    • /
    • pp.197-203
    • /
    • 2012
  • Recent advances in bronchoscopy have led to changes in clinical diagnostics and therapeutics in pulmonary medicine. In diagnostic bronchoscopy, there have also been new developments in endobronchial ultrasound technology which may be incorporated into clinical practice in the near future. Functional bronchoscopy, which evaluates information such as airway pressure, airflow, or gas exchange, suggests promising clinical advances in the near future. In therapeutic bronchoscopy, bronchoscopic volume reduction is a novel approach for the treatment of severe emphysema. In this review, seven recently published articles representing current advances in bronchoscopy are summarized and discussed.

'Drawing' a Molecular Portrait of CIN and Cervical Cancer: a Review of Genome-Wide Molecular Profiling Data

  • Kurmyshkina, Olga V;Kovchur, Pavel I;Volkova, Tatyana O
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.16 no.11
    • /
    • pp.4477-4487
    • /
    • 2015
  • In this review we summarize the results of studies employing high-throughput methods of profiling of HPV-associated cervical intraepithelial neoplasia (CIN) and squamous cell cervical cancers at key intracellular regulatory levels to demonstrate the unique identity of the landscape of molecular changes underlying this oncopathology, and to show how these changes are related to the 'natural history' of cervical cancer progression and the formation of clinically significant properties of tumors. A step-wise character of cervical cancer progression is a morphologically well-described fact and, as evidenced by genome-wide screenings, it is indeed the consistent change of the molecular profiles of HPV-infected epithelial cells through which they progressively acquire the phenotypic hallmarks of cancerous cells. In this sense, CIN/cervical cancer is a unique model for studying the driving forces and mechanisms of carcinogenesis. Recent research has allowed definition of the whole-genome spectrum of both random and regular molecular alterations, as well as changes either common to processes of carcinogenesis or specific for cervical cancer. Despite the existence of questions that are still to be investigated, these findings are of great value for the future development of approaches for the diagnostics and treatment of cervical neoplasms.

A Pilot study to estimate the efficacy of foot reflexology on insomnia in cancer patient (암환자의 불면에 대한 발반사요법의 효과 : 예비임상연구)

  • Jung, Hyun jung
    • Journal of Korean Traditional Oncology
    • /
    • v.26 no.1
    • /
    • pp.49-59
    • /
    • 2021
  • Objective: Insomnia is a very common symptom of cancer and has a substantial effect on the patients' quality of life. This study aimed to identify the effects of foot reflexology on insomnia in cancer patients. Methods: The study employed a before-after test design on a single group of 13 cancer patients with insomnia, selected by convenience sampling in Daegu. The foot reflexology treatment comprised 30-min sessions twice a week over four weeks. Pittsburgh Sleep Quality Index (PSQI) and Insomnia Severity Index (ISI) were measured at the baseline, at 2 and 4 weeks, and after 4 weeks post treatment completion. Brief Fatigue Inventory-Korean (BFI-K), Functional Assessment of Cancer Therapy-General (FACT-G), and Heart Rate Variability (HRV) were measured at baseline, post-treatment, and 4 weeks after completing treatments. Results: Thirteen patients (mean age 44.77 ± 6.70 years), with thyroid, breast or cervical cancer, were included in the study. Post-treatment, PSQI (from 12.33 ± 3.17 to 8.54 ± 3.43, p<0.001), ISI (from 20.33 ± 3.88 to 13.38 ± 4.23, p<0.001), FACT-G (from 49.6 ± 13.27 to 61.35 ± 14.45, p<0.001), and BFI (from 6.46 ± 0.91 to 5.00 ± 2.02, p<0.001) scores improved significantly over those at the baseline. Conclusion: Foot reflexology can be a good alternative treatment to improve insomnia, fatigue, and quality of life in cancer patients